Caribou Biosciences (CRBU) Free Cash Flow (2020 - 2026)
Caribou Biosciences (CRBU) reported Free Cash Flow of -$27.0 million for Q1 2026, up 26.71% year-over-year from -$21.3 million in Q1 2025, and down 30.97% quarter-over-quarter from -$20.6 million in Q4 2025.
Caribou Biosciences (CRBU) Free Cash Flow (2020 - 2026) Analysis & Trends
Caribou Biosciences (CRBU) has 7 years of Free Cash Flow data on file, last reported at -$27.0 million in Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$27.0 million, up 26.71% year-over-year; the trailing twelve-month figure through Mar 2026 was -$102.5 million (up 25.57% YoY), and the FY2025 annual result was -$112.4 million, up 19.14% from the prior year.
- Free Cash Flow fell to -$27.0 million in Q1 2026 per CRBU's latest filing, from -$20.6 million in the prior quarter.
- Over five years, Free Cash Flow peaked at -$18.1 million in Q2 2023 and troughed at -$38.1 million in Q1 2024.
- A 5-year average of -$27.3 million and a median of -$26.4 million in 2022 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2022 and 2025: Free Cash Flow tumbled 211.65% in 2022, then surged 42.5% in 2025.
- A 5-year view of Free Cash Flow shows it stood at -$21.6 million in 2022, then gained by 0.25% to -$21.5 million in 2023, then slumped by 66.63% to -$35.9 million in 2024, then surged by 42.5% to -$20.6 million in 2025, then slumped by 30.97% to -$27.0 million in 2026.
- Business Quant data shows CRBU's Free Cash Flow at -$27.0 million in Q1 2026, -$20.6 million in Q4 2025, and -$25.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Caribou Biosciences | 156.73 Mn | 39.11 Mn | - | -27.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.00 Mn |
| Mar 31, 2026 | -27.00 Mn |
| Dec 31, 2025 | -20.62 Mn |
| Dec 31, 2025 | -20.62 Mn |
| Sep 30, 2025 | -25.30 Mn |
| Sep 30, 2025 | -25.30 Mn |
| Jun 30, 2025 | -29.60 Mn |
| Jun 30, 2025 | -29.60 Mn |
| Mar 31, 2025 | -36.84 Mn |
| Mar 31, 2025 | -36.84 Mn |
| Dec 31, 2024 | -35.85 Mn |
| Dec 31, 2024 | -35.85 Mn |
| Sep 30, 2024 | -32.86 Mn |
| Sep 30, 2024 | -32.86 Mn |
| Jun 30, 2024 | -32.19 Mn |
| Jun 30, 2024 | -32.19 Mn |
| Mar 31, 2024 | -38.05 Mn |
| Mar 31, 2024 | -38.05 Mn |
| Dec 31, 2023 | -21.52 Mn |
| Dec 31, 2023 | -21.52 Mn |